Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30250% above fair value
$149.52+3.19 (+2.18%)
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Welireg (belzutifan by Year
Welireg (belzutifan — HIF-2α inhibitor) — Worldwide sales ($M) ($M)
Merck Welireg (belzutifan: $716M in FY2025, up 40.7% from a year earlier.
Latest, FY2025
716
Period ended Dec 31, 2025
Change on a year earlier
+40.7%
509 in FY2024
History
5 years
Since FY2021
Sources
5
Documents cited below
Where the FY2025 figure comes from
“|| Welireg | 199 | 271 | 470 | 137 | 162 | 300 | 196 | 220 | 716 | 67 | 67 | 57 | 56”
Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Segment & Product Sales Footnote & Form 8-K Table 3 / 3a / 3b.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Welireg (belzutifan — HIF-2α inhibitor) — Worldwide sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 716 | +40.7% | Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗ |
| FY2024 | Dec 31, 2024 | 509 | +133.5% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2023 | Dec 31, 2023 | 218 | +77.2% | Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗ |
| FY2022 | Dec 31, 2022 | 123 | +846.2% | Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗ |
| FY2021 | Dec 31, 2021 | 13 | – | Form 10-K (filed 2024-02-26) ↗ |
Breakdown
What makes up welireg (belzutifan
- Welireg (belzutifan — HIF-2α inhibitor) — U.S. sales ($M)603 · FY2025
- Welireg (belzutifan — HIF-2α inhibitor) — International sales ($M)113 · FY2025
- Welireg (belzutifan — HIF-2α inhibitor) — Worldwide reported growth YoY (%)41.0% · FY2025
- Welireg (belzutifan — HIF-2α inhibitor) — Worldwide constant-currency (ex-exchange) growth YoY (%)41.0% · FY2025
Cite this data
StockData. (2026). Merck Welireg (belzutifan ($M), annual FY2021–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-welireg
See every metric in the Merck KPI table. Data updated Oct 26, 2026.